Status:
COMPLETED
Copeptin- Relevance as a Perioperative Marker in Pediatric Cardiac Surgery
Lead Sponsor:
Claudia Herbst
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
Up to 6 years
Brief Summary
This study evaluates the relevance of Copeptin in children with congenital heart disease undergoing cardiac surgery with the need of cardiopulmonary bypass. Three blood samples are taken of each patie...
Detailed Description
Objective: Vasopressin is a hormone secreted by the posterior pituitary gland. Its main functions are constriction of blood vessels and reabsorption of water and thereby regulating water balance and ...
Eligibility Criteria
Inclusion
- ≤6 years of age
- CHD
- need of HLM for surgery
- Informed consent of parents
- not participating in other studies
Exclusion
- Preoperative ventilatory support
- Preoperative circulatory support (ECMO, VAD)
- Diabetes insipidus
- Preoperative CPR
- Preoperative shock
- Preoperative sepsis
- Preoperative vasopressin application
Key Trial Info
Start Date :
June 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2019
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT03316508
Start Date
June 14 2017
End Date
August 10 2019
Last Update
September 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090